This is a Validated Antibody Database (VAD) review about human cytokeratin 14, based on 176 published articles (read how Labome selects the articles), using cytokeratin 14 antibody in all methods. It is aimed to help Labome visitors find the most suited cytokeratin 14 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
cytokeratin 14 synonym: CK14; EBS3; EBS4; K14; NFJ

Invitrogen
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
Invitrogen cytokeratin 14 antibody (eBioscience, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 4a). Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; rhesus macaque; 0.2 ug/ml; loading ...; fig 4g
Invitrogen cytokeratin 14 antibody (Thermo Fisher, 41-9003-82) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 0.2 ug/ml (fig 4g). Science (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1a
Invitrogen cytokeratin 14 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1a). Nat Cell Biol (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig 1h
Invitrogen cytokeratin 14 antibody (Thermo Fisher Scientific, PA5-28002) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 1h). Sci Adv (2020) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry; mouse; 1:800; fig 2c
Invitrogen cytokeratin 14 antibody (Thermo Fisher, MA5-C11599) was used in immunohistochemistry on mouse samples at 1:800 (fig 2c). Cell Stem Cell (2019) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; fig 4, 5
Invitrogen cytokeratin 14 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples (fig 4, 5). Breast Cancer Res (2019) ncbi
domestic rabbit polyclonal
  • mass cytometry; human; loading ...; fig 3a
Invitrogen cytokeratin 14 antibody (ThermoFisher, PA5-16722) was used in mass cytometry on human samples (fig 3a). Cell (2019) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry; dogs; loading ...; fig 5a
Invitrogen cytokeratin 14 antibody (Thermo Fisher, LL002) was used in immunohistochemistry on dogs samples (fig 5a). J Histochem Cytochem (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 7a
Invitrogen cytokeratin 14 antibody (ThermoFisher, PA5-16722) was used in immunohistochemistry - paraffin section on mouse samples (fig 7a). Invest Ophthalmol Vis Sci (2017) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; human; loading ...; fig s1b
In order to study the suppressive effect of DNAJB6 and Hsp70 on alpha-synuclein aggregation, Invitrogen cytokeratin 14 antibody (Thermo Fischer, MA5-13203) was used in immunocytochemistry on human samples (fig s1b). Sci Rep (2017) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry; mouse; loading ...; fig 4e
In order to identify hair shaft progenitors for hair pigmentation, Invitrogen cytokeratin 14 antibody (Thermo, LL002) was used in immunohistochemistry on mouse samples (fig 4e). Genes Dev (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; tbl 2
In order to describe the differences between Xp11 translocation renal cell carcinoma and the corresponding mesenchymal neoplasm, Invitrogen cytokeratin 14 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - frozen section; mouse; 1:500; fig 3n
In order to discover that myoepithelial cells born early during submucosal gland morphogenesis are multipotent progenitors with the capacity to differentiate into other glandular cell types, Invitrogen cytokeratin 14 antibody (Thermo Fisher Scientific, MA5-11599) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 3n). Am J Respir Cell Mol Biol (2017) ncbi
mouse monoclonal (LL002)
  • immunocytochemistry; human; 1:25; loading ...; fig 2
In order to discuss estrogen receptor regulation and function in normal breast and breast cancer, Invitrogen cytokeratin 14 antibody (NeoMarkers, LL002) was used in immunocytochemistry on human samples at 1:25 (fig 2). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:4000; loading ...; fig 1c, ED1g
  • western blot; human; 1:2000; loading ...; fig 2c, ED4b
  • immunocytochemistry; mouse; 1:500
In order to define the interaction between LATS1/2 and the estrogen receptor signaling in breast cancer initiation., Invitrogen cytokeratin 14 antibody (Thermo Scientific, RB-9020) was used in immunocytochemistry on human samples at 1:4000 (fig 1c, ED1g), in western blot on human samples at 1:2000 (fig 2c, ED4b) and in immunocytochemistry on mouse samples at 1:500. Nature (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:5000; fig 3b
In order to discover that human polyomavirus 6 and human polyomavirus 7 are associated with rare, pruritic skin eruptions with a distinctive histologic pattern, Invitrogen cytokeratin 14 antibody (Thermo Fisher, PA5-28002) was used in immunohistochemistry - paraffin section on human samples at 1:5000 (fig 3b). J Am Acad Dermatol (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; loading ...; fig 3d
In order to discuss a case of mixed adenoneuroendocrine carcinoma of stomach with tubular adenoma and well-differentiated neuroendocrine tumor in the primary tumor in the stomach, Invitrogen cytokeratin 14 antibody (Thermo Scientific, AE1-AE3) was used in immunohistochemistry on human samples (fig 3d). Case Rep Pathol (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1h
In order to determine the mechanisms of itch in a mouse model of poison ivy allergic contact dermatitis, Invitrogen cytokeratin 14 antibody (Pierce, PA-5-13672) was used in immunohistochemistry - frozen section on mouse samples (fig 1h). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry; mouse; fig 1
In order to elucidate the mechanism by which RIPK1 counteracts RIPK3-MLKL-mediated necroptosis, Invitrogen cytokeratin 14 antibody (Neomarkers, MS-115) was used in immunohistochemistry on mouse samples (fig 1). Nature (2016) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 6a
In order to use knockout mice to determine the role of a2V in mammary gland development, Invitrogen cytokeratin 14 antibody (Thermo Fisher, MA5-11599) was used in immunohistochemistry - frozen section on mouse samples (fig 6a). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1b
In order to determine if PIK3CA mutations contribute to tumor initiation, Invitrogen cytokeratin 14 antibody (Thermo Scientific, RB-9020) was used in immunohistochemistry - paraffin section on mouse samples (fig 1b). Oncogenesis (2016) ncbi
mouse monoclonal (34betaE12)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to use MAML2 staining to distinguish cases of hyalinizing clear cell carcinoma from mucoepidermoid carcinoma, Invitrogen cytokeratin 14 antibody (Thermo Scientific, 34betaE12) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; mouse; loading ...; fig 3c
  • western blot; mouse; loading ...; fig 3d
In order to identify keratin-associated protein 5-5 as a driver of endothelial monolayer invasion, Invitrogen cytokeratin 14 antibody (Thermo Scientific, MA5-13203) was used in immunocytochemistry on mouse samples (fig 3c) and in western blot on mouse samples (fig 3d). Oncogene (2017) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - frozen section; mouse; 1:800; fig 8
In order to assess the transiently formed junctional nexuses during post-natal mammary gland development by E-cadherins, connexins, beta-catenin, and claudin-7, Invitrogen cytokeratin 14 antibody (Thermo Scientific, LL002) was used in immunohistochemistry - frozen section on mouse samples at 1:800 (fig 8). Dev Biol (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5b
In order to investigate inflammatory responses present at the breast cancer biopsy wound site, Invitrogen cytokeratin 14 antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 5b). Breast Cancer Res Treat (2016) ncbi
mouse monoclonal (LL002)
  • immunocytochemistry; human; fig 2d
  • western blot; human
  • immunohistochemistry; mouse; loading ...; fig 1a
In order to examine the effects of the FAM83H mutation on the keratin cytoskeleton and desmosomes in ameloblasts, Invitrogen cytokeratin 14 antibody (Thermo Scientific, LL002) was used in immunocytochemistry on human samples (fig 2d), in western blot on human samples and in immunohistochemistry on mouse samples (fig 1a). Sci Rep (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:50; fig 1
In order to analyze the induction of apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue by cisplatin and doxorubicin, Invitrogen cytokeratin 14 antibody (ThermoFisher Scientific, MA5-13156) was used in immunocytochemistry on human samples at 1:50 (fig 1). Future Oncol (2016) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; mouse; 1:300; fig 1
In order to investigate breast tumorigenesis due to loss of Panx1 which impairs mammary gland development at lactation, Invitrogen cytokeratin 14 antibody (Neomarkers, CL002) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; mouse; fig 1
In order to assess the effect of Notch1 inactivation in oroesophageal epithelium, Invitrogen cytokeratin 14 antibody (ThermoFisher Scientific, LL002) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Biochem Biophys Res Commun (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; fig s3
In order to test if the operating room environment contains human skin bacteria that could be seeding C-section born infants, Invitrogen cytokeratin 14 antibody (Molecular Probes, 985542A) was used in immunohistochemistry - paraffin section on human samples (fig s3). Microbiome (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; fig s3
In order to determine how sensitivity is restored in resistant ovarian cancer cells by targeting the Ras-MAPK pathway by miR-634, Invitrogen cytokeratin 14 antibody (Neomarkers, MS-343-P) was used in immunohistochemistry on human samples (fig s3). Mol Cancer (2015) ncbi
mouse monoclonal (PAN-CK)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to describe functionally enriched ES cell transgenics, Invitrogen cytokeratin 14 antibody (Thermo Scientific, MA5-13203) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Sci Rep (2015) ncbi
mouse monoclonal (LL002)
  • immunocytochemistry; human; 1:25; fig 2a
In order to analyze propagation of oestrogen-responsive and oestrogen receptor-positive normal human breast cells in culture, Invitrogen cytokeratin 14 antibody (NeoMarkers, MS-115-P) was used in immunocytochemistry on human samples at 1:25 (fig 2a). Nat Commun (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
In order to determine the desmoplastic interface in xenograft tumor in mice comprised of stromal and endothelial cells, Invitrogen cytokeratin 14 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Pathol Res Pract (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; mouse; 1:100; loading ...; tbl 2
In order to investigate if conditioned medium from proliferating fibroblasts induce a subset of hematopoietic cells to become adherent fibroblast-like cells, Invitrogen cytokeratin 14 antibody (eBioscience, 41-9003) was used in immunocytochemistry on mouse samples at 1:100 (tbl 2). J Cell Physiol (2016) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 5
In order to discuss Cx26 knockout in DMBA-induced mouse models and breast cancer, Invitrogen cytokeratin 14 antibody (Thermo Fisher Scientific, Ms-115-P) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5). Oncotarget (2015) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; human; 1:25; loading ...; fig 1b
In order to study thymus tissues derived from autopsies of individuals exposed to atomic bomb radiation in Hiroshima, Invitrogen cytokeratin 14 antibody (Thermo Scientific, LL002) was used in immunohistochemistry - paraffin section on human samples at 1:25 (fig 1b). J Histochem Cytochem (2016) ncbi
domestic rabbit polyclonal
In order to study three-dimensional tissues by programmed synthesis, Invitrogen cytokeratin 14 antibody (Thermo, RB-9020-P) was used . Nat Methods (2015) ncbi
domestic rabbit polyclonal
In order to elucidate the potential of PIK3CA to induce multipotency during tumorigenesis in the mammary gland, Invitrogen cytokeratin 14 antibody (Thermo Scientific, Rb9020) was used . Nature (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 2
In order to study a northern New England hospital and increased utilization, verification, and clinical implications of immunocytochemistry, Invitrogen cytokeratin 14 antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry on human samples (tbl 2). Diagn Cytopathol (2015) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry; human
In order to study the PHGDH expression in mammary tissue from the patients with triple negative breast cancer, Invitrogen cytokeratin 14 antibody (NeoMarkers, LL002) was used in immunohistochemistry on human samples . Mol Oncol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; carp
In order to establish and characterize a new cell line generated from the caudal fin tissue of ornamental common carp, Invitrogen cytokeratin 14 antibody (Life Technologies, MA5-13156) was used in immunocytochemistry on carp samples . In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human
  • immunocytochemistry; human; 1 ul
Invitrogen cytokeratin 14 antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples and in immunocytochemistry on human samples at 1 ul. Nanomedicine (2015) ncbi
mouse monoclonal (C11)
  • western blot; human; 1:1000
In order to develop an immunofluorescence method to assess MCT1 and MCT4 in circulating tumor cells and as them as biomarkers of AZD3965 in cancer patients, Invitrogen cytokeratin 14 antibody (Thermo Scientific, 4545) was used in western blot on human samples at 1:1000. BMC Cancer (2015) ncbi
mouse monoclonal (PAN-CK)
  • western blot; human
In order to study the impact of TNF-alpha and IL-1beta on the inflammatory phenotype of cancer-associated fibroblasts and mesenchymal stem/stromal cells, Invitrogen cytokeratin 14 antibody (Thermo Fisher Scientific, MA5-13203) was used in western blot on human samples . Stem Cell Res Ther (2015) ncbi
domestic rabbit polyclonal
In order to study and identify critical cell lineage-dependent transduction bias to model breast cancer properly, Invitrogen cytokeratin 14 antibody (Neomarkers/Thermo, Rb-9020) was used . Nat Commun (2015) ncbi
mouse monoclonal (AE1/AE3)
In order to generate and characterize a thymic cell line derived from Channa striatus, Invitrogen cytokeratin 14 antibody (Invitrogen, AE1/AE3) was used . In Vitro Cell Dev Biol Anim (2015) ncbi
domestic rabbit polyclonal
In order to evaluate the effect of aspirin in mesenchymal to epithelial transition, Invitrogen cytokeratin 14 antibody (Thermo Scientific, RB-9021) was used . Lab Invest (2015) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry; human; 1:100
In order to develop a 3D human skin equivalent containing blood and lymph-like capillary networks, Invitrogen cytokeratin 14 antibody (NeoMarkers, MS115P0) was used in immunohistochemistry on human samples at 1:100. J Biomed Mater Res A (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; domestic horse; 1:100
In order to discuss using induced pluripotent stem cells to promote wound healing in various animals, Invitrogen cytokeratin 14 antibody (Fisher Scientific, MA1-82041) was used in immunocytochemistry on domestic horse samples at 1:100. Equine Vet J (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 10-20 ug/ml
In order to identify biomarkers for nasopharyngeal carcinoma, Invitrogen cytokeratin 14 antibody (Lab.Vision, Ab-1) was used in immunohistochemistry - paraffin section on human samples at 10-20 ug/ml. Asian Pac J Cancer Prev (2015) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; cat; 1:300
  • immunohistochemistry - paraffin section; dogs; 1:300
Invitrogen cytokeratin 14 antibody (NeoMarkers, LL002) was used in immunohistochemistry - paraffin section on cat samples at 1:300 and in immunohistochemistry - paraffin section on dogs samples at 1:300. J Comp Pathol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen cytokeratin 14 antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen cytokeratin 14 antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; zebrafish ; 1:100; fig 5
In order to report that mice and zebrafish exposed to high-fat or high-cholesterol diets develop acute innate inflammatory responses in the intestine, Invitrogen cytokeratin 14 antibody (Thermo Fisher Scientific, MA1-82041) was used in flow cytometry on zebrafish samples at 1:100 (fig 5). Nat Commun (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 5
In order to determine the link between cell cycle control and proliferative potential of epidermal progenitor cells by the carboxy-terminus of p63, Invitrogen cytokeratin 14 antibody (ThermoFisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5). Development (2015) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry; human; ready-to-use
In order to describe a tumor from a patient with oncocytic cystadenoma, Invitrogen cytokeratin 14 antibody (Thermo Scientific, AE1) was used in immunohistochemistry on human samples at ready-to-use. Medicine (Baltimore) (2014) ncbi
mouse monoclonal (AE-1)
  • immunohistochemistry; human; ready-to-use
In order to describe a tumor from a patient with oncocytic cystadenoma, Invitrogen cytokeratin 14 antibody (Thermo Scientific, AE1) was used in immunohistochemistry on human samples at ready-to-use. Medicine (Baltimore) (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess the prognostic value of immunohistochemical markers in nonhuman primates, Invitrogen cytokeratin 14 antibody (Neo Markers, MS343) was used in immunohistochemistry - paraffin section on human samples at 1:100. Comp Med (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, Invitrogen cytokeratin 14 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Nat Cell Biol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen cytokeratin 14 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Hum Pathol (2014) ncbi
mouse monoclonal (34betaE12)
  • immunohistochemistry - paraffin section; human; 1:50
In order to describe two cases of trichilemmal carcinoma, Invitrogen cytokeratin 14 antibody (Thermo Fisher Scientific, 34betaE12) was used in immunohistochemistry - paraffin section on human samples at 1:50. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen cytokeratin 14 antibody (Thermo Fisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
In order to determine the role of myofibroblasts in salivary gland adenoid cystic carcinoma invasiveness, Invitrogen cytokeratin 14 antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on human samples . Histopathology (2015) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry; human; fig 1
In order to establish an in vitro system to study three-dimensional corneal differentiation, Invitrogen cytokeratin 14 antibody (Thermo Fisher Scientific, MS115B0) was used in immunohistochemistry on human samples (fig 1). Nature (2014) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; mouse; 1:500
In order to develop a small animal model to study orthotopic tracheal transplantation, Invitrogen cytokeratin 14 antibody (Thermo/Neomarkers, MS-115-P0) was used in immunohistochemistry - paraffin section on mouse samples at 1:500. Tissue Eng Part A (2015) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; mouse
In order to study p65-dependent NF-kapaB signaling in keratinocytes and its contribution to skin carcinogenesis, Invitrogen cytokeratin 14 antibody (Thermoscientific, MS115) was used in immunohistochemistry - paraffin section on mouse samples . EMBO Mol Med (2014) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; human
In order to develop a 3D lung model using human bronchial epithelial cells, Invitrogen cytokeratin 14 antibody (Thermo Scientific, MS-115-P) was used in immunohistochemistry - paraffin section on human samples . Differentiation (2014) ncbi
mouse monoclonal (LL002)
  • immunocytochemistry; human; 1:25
  • immunohistochemistry; human; 1:25
In order to investigate the role of CEACAM6 in luminal, HER2-enriched, and basal-like breast cancers, Invitrogen cytokeratin 14 antibody (NeoMarkers, LL002) was used in immunocytochemistry on human samples at 1:25 and in immunohistochemistry on human samples at 1:25. Am J Pathol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human
In order to test if computed tomography-lymphography distinguishes sentinel nodes from non-sentinel nodes in patients with breast cancer, Invitrogen cytokeratin 14 antibody (Thermo, AE1/AE3) was used in immunohistochemistry on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
Invitrogen cytokeratin 14 antibody (Thermo Fisher, AE1/AE3) was used in immunocytochemistry on human samples . Biomed Mater (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human
In order to determine the predictive criteria of the size of nodal metastases with superparamagnetic iron oxide-enhanced MR imaging in breast cancer, Invitrogen cytokeratin 14 antibody (Thermoelectron, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to report the clinicopathological features of 9 breast malignant fibrous histiocytoma patients, Invitrogen cytokeratin 14 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Sci Rep (2013) ncbi
mouse monoclonal (LL002)
  • immunocytochemistry; human; 1:400; fig s1
In order to review the contribution of Yes Associated Protein to various types of cancer, Invitrogen cytokeratin 14 antibody (Neomarkers, MS-115-P) was used in immunocytochemistry on human samples at 1:400 (fig s1). Cell Oncol (Dordr) (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:100; fig 1
Invitrogen cytokeratin 14 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples at 1:100 (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; human; 1:200; fig 2
In order to describe the molecular pathologic characteristics of urothelial carcinomas subtypes, Invitrogen cytokeratin 14 antibody (Lab Vision, MS-115) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2). Am J Pathol (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 1
In order to characterize a case of malignant ossifying fibromyxoid tumor in the tongue, Invitrogen cytokeratin 14 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (tbl 1). Head Face Med (2013) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry; mouse
In order to study the effects of conditional epidermal knockout of HDAC-1 and -2 on murine ectodermal organ morphogenesis, Invitrogen cytokeratin 14 antibody (Lab Vision, MS-115) was used in immunohistochemistry on mouse samples . J Invest Dermatol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:200; fig 4
In order to present the third case of thymoma and the second invasive thymoma to metastasize to the cavernous sinus and adjacent to the pituitary, Invitrogen cytokeratin 14 antibody (Zymed, AE1-AE3) was used in immunohistochemistry on human samples at 1:200 (fig 4). Surg Neurol Int (2013) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; mouse; 1:200; tbl 2
In order to determine the expression and function of KLF5 in prostatic epithelial homeostasis and tumorigenesis, Invitrogen cytokeratin 14 antibody (Thermo Scientific, MS-115-P0) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (tbl 2). PLoS ONE (2013) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; mouse; fig 1c
In order to use a mouse model to examine the link between the microbiota and atopic dermatitis, Invitrogen cytokeratin 14 antibody (Neomarkers, LL002) was used in immunohistochemistry - paraffin section on mouse samples (fig 1c). J Invest Dermatol (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; fig 2
In order to present a case of not otherwise specified-type sarcoma with CD10 expression in the left breast, Invitrogen cytokeratin 14 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (fig 2). Diagn Pathol (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; Atlantic salmon; 1:50; fig 2
In order to study cell tropism of infectious salmon anemia virus, Invitrogen cytokeratin 14 antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on Atlantic salmon samples at 1:50 (fig 2). Virol J (2013) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; dogs; 1:300
In order to determine the relationship between the molecular phenotype of the primary canine mammary tumors and lymph node metastasis, Invitrogen cytokeratin 14 antibody (NeoMarkers, Ab-1 (LL002)) was used in immunohistochemistry - paraffin section on dogs samples at 1:300. BMC Vet Res (2012) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; dogs; 1:300; tbl 2
In order to assess a panel of markers for the identification of four different myoepithelial cell morphological types in normal and neoplastic mammary glands, Invitrogen cytokeratin 14 antibody (NeoMarkers, Ab-1 (LL002)) was used in immunohistochemistry - paraffin section on dogs samples at 1:300 (tbl 2). ScientificWorldJournal (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to review features of choroid plexus carcinoma, Invitrogen cytokeratin 14 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Med Sci Monit (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse
In order to investigate the positioning of taste buds in circumvallate papilla and branching morphogenesis of von Ebners' gland in tongue development, Invitrogen cytokeratin 14 antibody (Thermo Scientific, MS-343) was used in immunohistochemistry - paraffin section on mouse samples . Anat Cell Biol (2011) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - paraffin section; human; 1:100
  • immunocytochemistry; human; 1:100
In order to investigate epithelial to mesenchymal transition during metastasis of pancreatic cancer, Invitrogen cytokeratin 14 antibody (Labvision, MS-149) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunocytochemistry on human samples at 1:100. Br J Cancer (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200
In order to examine the suitability of PAXgene tissue fixation for (immuno)histological methods, Invitrogen cytokeratin 14 antibody (Neomarkers, MS 343-P) was used in immunohistochemistry - paraffin section on human samples at 1:200. PLoS ONE (2011) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 0.4 ug/ul; fig 1
In order to develop an in vitro model for experimental studies of cancer cell invasion, Invitrogen cytokeratin 14 antibody (NeoMarkers, MS-343) was used in immunohistochemistry on human samples at 0.4 ug/ul (fig 1). Eur J Oral Sci (2010) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry; mouse; 1:100
  • western blot; mouse; 1:100
In order to study the role of Sox2 in the maintenance and differentiation of bronchiolar cells, Invitrogen cytokeratin 14 antibody (Neomarkers, LL002) was used in immunohistochemistry on mouse samples at 1:100 and in western blot on mouse samples at 1:100. PLoS ONE (2009) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen cytokeratin 14 antibody (Zymed, AE1) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (AE-1)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen cytokeratin 14 antibody (Zymed, AE1) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen cytokeratin 14 antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen cytokeratin 14 antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200
In order to discuss the morphological diversity of glioblastomas, Invitrogen cytokeratin 14 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:200. Cancer (2008) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; human; 1:400
  • immunohistochemistry; human; 1:400
In order to study the use of tissue microarrays for immunohistochemical analysis of squamous cell carcinoma markers, Invitrogen cytokeratin 14 antibody (Neomarkers, LL002) was used in immunohistochemistry - paraffin section on human samples at 1:400 and in immunohistochemistry on human samples at 1:400. Virchows Arch (2008) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry; human; 1:1000; tbl 3
In order to investigate the sub-classification invasive breast carcinoma patients and its prognostic significance, Invitrogen cytokeratin 14 antibody (Lab Vision/Neomarkers, LL002) was used in immunohistochemistry on human samples at 1:1000 (tbl 3). Cancer (2007) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; fig 5
In order to investigate the effect of COX-2 overexpression on inhibiting proliferation, apoptosis and differentiation, Invitrogen cytokeratin 14 antibody (Lab Vision, MS-343-P) was used in western blot on human samples (fig 5). Int J Cancer (2005) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen cytokeratin 14 antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen cytokeratin 14 antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:80; tbl 1
In order to describe four cases of oncocytic adrenocortical carcinomas, Invitrogen cytokeratin 14 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:80 (tbl 1). Pathol Int (2004) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; human; 1:500
In order to identify biomarkers for head and neck squamous cell carcinoma, Invitrogen cytokeratin 14 antibody (NeoMarkers, MS-115-P1) was used in immunohistochemistry - paraffin section on human samples at 1:500. Cancer Cell (2004) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; 1:1000; fig 2
In order to study how cell-matrix interactions influence the invasive behavior of a novel, primary peritoneal carcinosarcoma cell line, Invitrogen cytokeratin 14 antibody (Zymed, AE1/AE3) was used in western blot on human samples at 1:1000 (fig 2). Gynecol Oncol (2003) ncbi
Abcam
mouse monoclonal (LL002)
  • immunocytochemistry; human; 1:500; loading ...; fig 1a
  • western blot; human; 1:5000; loading ...; fig 1h
Abcam cytokeratin 14 antibody (Abcam, LL002) was used in immunocytochemistry on human samples at 1:500 (fig 1a) and in western blot on human samples at 1:5000 (fig 1h). Sci Adv (2021) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig s4g
Abcam cytokeratin 14 antibody (Abcam, ab7800) was used in immunohistochemistry on mouse samples at 1:1000 (fig s4g). Nat Commun (2020) ncbi
domestic rabbit monoclonal (EPR17350)
  • flow cytometry; human; loading ...; fig 1d
  • immunocytochemistry; human; loading ...; fig 3e
Abcam cytokeratin 14 antibody (Abcam, ab181595) was used in flow cytometry on human samples (fig 1d) and in immunocytochemistry on human samples (fig 3e). Cell Stem Cell (2020) ncbi
domestic rabbit monoclonal (EPR17350)
  • western blot; human; 1:4000; loading ...; fig 4b
  • immunohistochemistry - paraffin section; mouse; 1:4000; loading ...; fig 3b
  • western blot; mouse; 1:4000; loading ...; fig 4a
Abcam cytokeratin 14 antibody (Abcam, ab1851595) was used in western blot on human samples at 1:4000 (fig 4b), in immunohistochemistry - paraffin section on mouse samples at 1:4000 (fig 3b) and in western blot on mouse samples at 1:4000 (fig 4a). Biomol Ther (Seoul) (2019) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 4g
Abcam cytokeratin 14 antibody (Abcam, ab7800) was used in immunohistochemistry - frozen section on mouse samples (fig 4g). Cell Rep (2019) ncbi
domestic rabbit monoclonal (EPR17350)
  • immunohistochemistry - paraffin section; mouse; 1:6000; loading ...; fig 1b
Abcam cytokeratin 14 antibody (ABCAM, ab181595) was used in immunohistochemistry - paraffin section on mouse samples at 1:6000 (fig 1b). Nat Commun (2019) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 2a
Abcam cytokeratin 14 antibody (Abcam, ab7800) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 2a). Cell Death Dis (2018) ncbi
domestic rabbit monoclonal (EP1612Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1b
Abcam cytokeratin 14 antibody (Abcam, ab51054) was used in immunohistochemistry - paraffin section on human samples (fig 1b). Ann Rheum Dis (2018) ncbi
mouse monoclonal (LL002)
  • western blot; human; loading ...; fig 1b
Abcam cytokeratin 14 antibody (Abcam, ab7800) was used in western blot on human samples (fig 1b). Front Immunol (2018) ncbi
domestic rabbit monoclonal (EPR17350)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 1c
Abcam cytokeratin 14 antibody (Abcam, ab181595) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1c). Sci Rep (2018) ncbi
mouse monoclonal (LL002)
  • immunocytochemistry; mouse; loading ...; fig 2b
Abcam cytokeratin 14 antibody (Abcam, ab7800) was used in immunocytochemistry on mouse samples (fig 2b). Biochim Biophys Acta Mol Basis Dis (2018) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry; domestic rabbit; loading ...; fig 4
Abcam cytokeratin 14 antibody (Abcam, ab77684) was used in immunohistochemistry on domestic rabbit samples (fig 4). Int J Mol Med (2017) ncbi
mouse monoclonal (LL002)
  • immunocytochemistry; human; fig s1e
In order to define the interaction between LATS1/2 and the estrogen receptor signaling in breast cancer initiation., Abcam cytokeratin 14 antibody (Abcam, LL002) was used in immunocytochemistry on human samples (fig s1e). Nature (2017) ncbi
mouse monoclonal (LL002)
  • western blot; mouse; 1:1000; loading ...; fig 5a
Abcam cytokeratin 14 antibody (Abcam, ab7800) was used in western blot on mouse samples at 1:1000 (fig 5a). Oncotarget (2016) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
  • immunocytochemistry; human; 1:200; fig 1
Abcam cytokeratin 14 antibody (Abcam, ab7800) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1) and in immunocytochemistry on human samples at 1:200 (fig 1). Respir Res (2016) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; mouse; 1:1500; fig 1
In order to characterize the spontaneous peripheral squamous cell lung cancer in mice by ablation of liver X receptors alpha and beta, Abcam cytokeratin 14 antibody (Abcam, ab7800) was used in immunohistochemistry - paraffin section on mouse samples at 1:1500 (fig 1). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (LL002)
  • immunocytochemistry; human; 1:50; tbl 2
In order to research the function of keratinocyte expression of CRF and POMC, Abcam cytokeratin 14 antibody (Abcam, ab7800) was used in immunocytochemistry on human samples at 1:50 (tbl 2). J Cell Physiol (2017) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; human; 1:200; fig 2
  • western blot; human; 1:500; fig 5
Abcam cytokeratin 14 antibody (Abcam, ab7800) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2) and in western blot on human samples at 1:500 (fig 5). Int J Mol Med (2016) ncbi
mouse monoclonal (LL002)
  • western blot; human; loading ...; fig 2d
Abcam cytokeratin 14 antibody (Abcam, LL002) was used in western blot on human samples (fig 2d). Cell Cycle (2016) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 1
Abcam cytokeratin 14 antibody (Abcam, ab7800) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1). J Cell Biol (2016) ncbi
mouse monoclonal (LL002)
  • flow cytometry; human; fig 3
Abcam cytokeratin 14 antibody (Abcam, ab7800) was used in flow cytometry on human samples (fig 3). BMC Res Notes (2015) ncbi
mouse monoclonal (RCK107)
  • immunocytochemistry; mouse; 1:100; fig 1B
  • western blot; mouse; fig 1C
Abcam cytokeratin 14 antibody (Abcam, ab9220) was used in immunocytochemistry on mouse samples at 1:100 (fig 1B) and in western blot on mouse samples (fig 1C). Mol Med Rep (2016) ncbi
domestic rabbit monoclonal (EP1612Y)
  • other; human; 1:100; fig 6
Abcam cytokeratin 14 antibody (Abcam, ab51054) was used in other on human samples at 1:100 (fig 6). Cancer Cell Int (2015) ncbi
mouse monoclonal (LL002)
  • immunocytochemistry; human; 1:500; loading ...; fig 5
Abcam cytokeratin 14 antibody (Abcam, Ab7800) was used in immunocytochemistry on human samples at 1:500 (fig 5). PLoS ONE (2015) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 5
In order to analyze triple negative breast carcinomoas and their correlation with mesothelin expression and basal-like phenotype, decreased survival, and distant metastases, Abcam cytokeratin 14 antibody (Abcam, LL002) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 5). PLoS ONE (2014) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - frozen section; mouse
In order to examine the role of keratin 76 in tight junction function and maintenance of the skin barrier, Abcam cytokeratin 14 antibody (Abcam, ab7800) was used in immunohistochemistry - frozen section on mouse samples . PLoS Genet (2014) ncbi
mouse monoclonal (LL002)
  • western blot; human
Abcam cytokeratin 14 antibody (Abcam, ab7800) was used in western blot on human samples . Cancer Res (2014) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; mouse; 1:100
In order to study the effect of thyroid hormone on hair growth and skin homeostasis, Abcam cytokeratin 14 antibody (Abcam, Ab7800) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. PLoS ONE (2014) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; mouse; 1:250-1:1000
In order to examine the developing epidermis to determine the consequences of lipid dysregulation in mouse models, Abcam cytokeratin 14 antibody (Abcam, ab7800) was used in immunohistochemistry - paraffin section on mouse samples at 1:250-1:1000. Hum Mol Genet (2015) ncbi
mouse monoclonal (RCK107)
  • immunohistochemistry - frozen section; human
  • western blot; human
Abcam cytokeratin 14 antibody (Abcam, ab9220) was used in immunohistochemistry - frozen section on human samples and in western blot on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (SPK-14)
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 4
In order to identify MK2-dependent and -independent mechanisms of blister formation in a mouse model of pemphigus vulgaris, Abcam cytokeratin 14 antibody (Abcam, K14) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 4). J Invest Dermatol (2014) ncbi
BioLegend
chicken polyclonal (Poly9060)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 2f
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 1a, 1d, 2f,
BioLegend cytokeratin 14 antibody (BioLegend, SIG-3476-100) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 2f) and in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 1a, 1d, 2f, ). Nat Commun (2020) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunohistochemistry; mouse; 1:250; loading ...
BioLegend cytokeratin 14 antibody (Biolegend, 905301) was used in immunohistochemistry on mouse samples at 1:250. Nature (2019) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunohistochemistry; mouse; loading ...; fig 6d
BioLegend cytokeratin 14 antibody (Covance, PRB155P) was used in immunohistochemistry on mouse samples (fig 6d). Cell (2019) ncbi
chicken polyclonal (Poly9060)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5g
BioLegend cytokeratin 14 antibody (BioLegend, 906001) was used in immunohistochemistry - paraffin section on mouse samples (fig 5g). Cell (2019) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunohistochemistry; human; 1:100; loading ...; fig 5s1a
BioLegend cytokeratin 14 antibody (Covance, PRB-155P) was used in immunohistochemistry on human samples at 1:100 (fig 5s1a). elife (2019) ncbi
domestic rabbit polyclonal (Poly19053)
  • western blot; human; loading ...; fig 3a
BioLegend cytokeratin 14 antibody (BioLegend, 905304) was used in western blot on human samples (fig 3a). elife (2019) ncbi
chicken polyclonal (Poly9060)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1d
BioLegend cytokeratin 14 antibody (Covance, SIG-3476) was used in immunohistochemistry - frozen section on mouse samples (fig 1d). Cell (2019) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 4a
BioLegend cytokeratin 14 antibody (Biolegend, 905304) was used in immunohistochemistry on mouse samples at 1:1000 (fig 4a). Breast Cancer Res (2018) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunohistochemistry - paraffin section; mouse; fig 1b
BioLegend cytokeratin 14 antibody (Covance, PRB-155P) was used in immunohistochemistry - paraffin section on mouse samples (fig 1b). J Clin Invest (2018) ncbi
chicken polyclonal (Poly9060)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s5a
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s5a
BioLegend cytokeratin 14 antibody (BioLegend, Poly9060) was used in immunohistochemistry - frozen section on mouse samples (fig s5a) and in immunohistochemistry - paraffin section on mouse samples (fig s5a). J Cell Biol (2018) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 7a
BioLegend cytokeratin 14 antibody (Covance, PRB-155P) was used in immunohistochemistry - paraffin section on mouse samples (fig 7a). Invest Ophthalmol Vis Sci (2017) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3c
In order to understand the role of AP1 transcription factor in ichthyoses and collodion membrane formation, BioLegend cytokeratin 14 antibody (Covance, PRB-155P) was used in immunohistochemistry - paraffin section on mouse samples (fig 3c). J Invest Dermatol (2017) ncbi
chicken polyclonal (Poly9060)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 4b
In order to show that induction p53 loss in Krt8(+) mammary luminal cells leads to their clonal expansion without directly affecting their luminal identity, BioLegend cytokeratin 14 antibody (Covance, SIG-3476) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 4b). Nat Commun (2017) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunohistochemistry - paraffin section; mouse; 1:400; loading ...; fig 4b
In order to show that induction p53 loss in Krt8(+) mammary luminal cells leads to their clonal expansion without directly affecting their luminal identity, BioLegend cytokeratin 14 antibody (Covance, PRB-155P) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 4b). Nat Commun (2017) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunohistochemistry; mouse; 1:700; loading ...; fig s6b
BioLegend cytokeratin 14 antibody (Covance, PRB155P) was used in immunohistochemistry on mouse samples at 1:700 (fig s6b). Nature (2017) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 6a
In order to explore the role of Hic-5 in breast tumor progression, BioLegend cytokeratin 14 antibody (Covance, PRB-155P) was used in immunohistochemistry - frozen section on mouse samples (fig 6a). Oncogene (2017) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunohistochemistry; mouse; loading ...; fig 1b
In order to generate and characterize mice that lack CD44 in the skin, BioLegend cytokeratin 14 antibody (Covance, PRB.155P) was used in immunohistochemistry on mouse samples (fig 1b). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig S5B
In order to show that deletion of the gene encoding RAB guanine nucleotide exchange factor 1 in keratinocytes severely impairs epidermal barrier function in mice, BioLegend cytokeratin 14 antibody (Covance, PRB-155P) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig S5B). J Clin Invest (2016) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 6e
BioLegend cytokeratin 14 antibody (BioLegend, poly19053) was used in immunohistochemistry - frozen section on mouse samples (fig 6e). PLoS Pathog (2016) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunohistochemistry - paraffin section; mouse; 1:1000
  • immunocytochemistry; mouse; fig 2C
  • western blot; mouse; fig 2D
BioLegend cytokeratin 14 antibody (Covance, PRB-155P) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000, in immunocytochemistry on mouse samples (fig 2C) and in western blot on mouse samples (fig 2D). Stem Cell Res Ther (2016) ncbi
chicken polyclonal (Poly9060)
BioLegend cytokeratin 14 antibody (Biolegend, 906001) was used . Nat Commun (2016) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunohistochemistry; mouse; 1:5000; fig 3
In order to analyze the interaction between BRCA1 and COBRA1 in mammary gland development and how genetic suppression reveals DNA repair-independent antagonism, BioLegend cytokeratin 14 antibody (Covance, PRB-155P) was used in immunohistochemistry on mouse samples at 1:5000 (fig 3). Nat Commun (2016) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunocytochemistry; human; 1:300; loading ...; fig 2b
BioLegend cytokeratin 14 antibody (BioLegend, Poly19053) was used in immunocytochemistry on human samples at 1:300 (fig 2b). Cell Cycle (2016) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunohistochemistry - paraffin section; mouse; 1 ug/ml; fig 3
In order to investigate promotion of healing in a bacterial LPS model of delayed cutaneous wound repair by oestrogen, BioLegend cytokeratin 14 antibody (Covance, PRB-155 P) was used in immunohistochemistry - paraffin section on mouse samples at 1 ug/ml (fig 3). Lab Invest (2016) ncbi
domestic rabbit polyclonal (Poly19053)
  • immunocytochemistry; mouse; fig 3
In order to follow the presence of K14+ compound niches present in mouse cornea early after birth through expansion after debridement wounds, BioLegend cytokeratin 14 antibody (Covance, PRB-155p) was used in immunocytochemistry on mouse samples (fig 3). Dev Dyn (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (LL001)
  • immunohistochemistry; rat; 1:200; loading ...; fig 3e
Santa Cruz Biotechnology cytokeratin 14 antibody (Santa Cruz Biotechnology, sc53253) was used in immunohistochemistry on rat samples at 1:200 (fig 3e). Mol Pain (2020) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry; cat; 1:150; loading ...; fig 3l
Santa Cruz Biotechnology cytokeratin 14 antibody (Santa Cruz, sc-58,724) was used in immunohistochemistry on cat samples at 1:150 (fig 3l). BMC Cancer (2019) ncbi
mouse monoclonal (LL001)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 3b
  • western blot; mouse; 1:1000; loading ...; fig s5c
Santa Cruz Biotechnology cytokeratin 14 antibody (Santa, SC-53253) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 3b) and in western blot on mouse samples at 1:1000 (fig s5c). Nat Med (2018) ncbi
mouse monoclonal (LL001)
  • immunocytochemistry; mouse; 1:100; loading ...; fig 2a
Santa Cruz Biotechnology cytokeratin 14 antibody (Santacruz, sc-53253) was used in immunocytochemistry on mouse samples at 1:100 (fig 2a). Sci Rep (2017) ncbi
mouse monoclonal (LL001)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 2
In order to learn the requirement for epithelial cell fate decision in the lower mullerian duct by FGFR2IIIb-MAPK activity, Santa Cruz Biotechnology cytokeratin 14 antibody (Santa Cruz, sc-53253) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 2). Mol Endocrinol (2016) ncbi
mouse monoclonal (RCK107)
  • immunocytochemistry; human; 1:1000; fig 4
Santa Cruz Biotechnology cytokeratin 14 antibody (Santa Cruz, SC23878) was used in immunocytochemistry on human samples at 1:1000 (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (LL001)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to propose that RANK dictates WNT responsiveness to hormone-induced changes in adult mammary cells, Santa Cruz Biotechnology cytokeratin 14 antibody (Santa Cruz, sc-53253) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Stem Cell Reports (2015) ncbi
mouse monoclonal (LL001)
  • western blot; human
In order to assess the role of Shh signaling in bladder cancer, Santa Cruz Biotechnology cytokeratin 14 antibody (Santa Cruz, sc-53253) was used in western blot on human samples . Mol Carcinog (2016) ncbi
mouse monoclonal (LL001)
  • immunohistochemistry - paraffin section; mouse; 1:300; fig 3
In order to determine the link between cell cycle control and proliferative potential of epidermal progenitor cells by the carboxy-terminus of p63, Santa Cruz Biotechnology cytokeratin 14 antibody (Santa Cruz, LL001) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 3). Development (2015) ncbi
mouse monoclonal (LL002)
  • immunocytochemistry; mouse; fig 3
Santa Cruz Biotechnology cytokeratin 14 antibody (Santa Cruz, sc 58724) was used in immunocytochemistry on mouse samples (fig 3). Methods Mol Biol (2014) ncbi
Bio-Rad
mouse monoclonal (LL002)
  • immunohistochemistry - paraffin section; dogs; 1:200; loading ...; fig 3a
Bio-Rad cytokeratin 14 antibody (Serotec, LL002) was used in immunohistochemistry - paraffin section on dogs samples at 1:200 (fig 3a). J Vet Med Sci (2019) ncbi
mouse monoclonal (LL002)
  • immunohistochemistry; dogs; 1:100
Bio-Rad cytokeratin 14 antibody (Serotec, LL002) was used in immunohistochemistry on dogs samples at 1:100. J Comp Pathol (2014) ncbi
Abnova
domestic rabbit monoclonal (D19-N)
  • immunohistochemistry; pigs ; fig 3
Abnova cytokeratin 14 antibody (Abnova Corporation, MAB9766) was used in immunohistochemistry on pigs samples (fig 3). Gastrointest Endosc (2015) ncbi
Vector Laboratories
  • immunocytochemistry; human; loading ...; fig 2f
Vector Laboratories cytokeratin 14 antibody (Vector Laboratories, VPC410) was used in immunocytochemistry on human samples (fig 2f). Oncogene (2019) ncbi
  • immunocytochemistry; human; fig 4
In order to study the production of a dominantly-acting oncogene in human breast cancer due to premature polyadenylation of MAGI3, Vector Laboratories cytokeratin 14 antibody (Vector Laboratories, VP-C410) was used in immunocytochemistry on human samples (fig 4). elife (2016) ncbi
  • immunohistochemistry - frozen section; mouse
In order to profile the expression pattern of globose basal cells within the olfactory epithelium, Vector Laboratories cytokeratin 14 antibody (Vector, VP-C410) was used in immunohistochemistry - frozen section on mouse samples . J Comp Neurol (2013) ncbi
Leica Biosystems
mouse monoclonal
  • immunohistochemistry; mouse; loading ...; fig 2i
Leica Biosystems cytokeratin 14 antibody (Novocastra, NCL-L-LL002) was used in immunohistochemistry on mouse samples (fig 2i). J Dent Res (2017) ncbi
mouse monoclonal
  • immunohistochemistry; human; 1:50; loading ...; fig 1c
In order to discuss changes in the expression of mitochondrial ribosomal proteins in cancer, Leica Biosystems cytokeratin 14 antibody (Leica Biosystems, NCL-L-LL002) was used in immunohistochemistry on human samples at 1:50 (fig 1c). BMC Cancer (2017) ncbi
mouse monoclonal
  • immunohistochemistry - paraffin section; human; 1:20; tbl 2
In order to characterize triple-negative breast cancer and the role of epithelial-mesenchymal transition markers, Leica Biosystems cytokeratin 14 antibody (Leica Novocastra, NCL-L-LL002) was used in immunohistochemistry - paraffin section on human samples at 1:20 (tbl 2). Breast Cancer Res Treat (2015) ncbi
mouse monoclonal
  • immunohistochemistry - paraffin section; human; 1:20
In order to assess the clinicopathological and immunohistochemical characteristics, and the clinical outcomes, between screen-detected and symptomatic DCIS, Leica Biosystems cytokeratin 14 antibody (Leica Novocastra, NCL-L-LL002) was used in immunohistochemistry - paraffin section on human samples at 1:20. Breast Cancer Res Treat (2015) ncbi
monoclonal
  • immunohistochemistry - paraffin section; human; tbl 2
In order to analyze breast cancer subtypes and retrospective analysis of metastatic behaviour, Leica Biosystems cytokeratin 14 antibody (Leica, LL002) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Breast Cancer Res Treat (2015) ncbi
mouse monoclonal
  • immunohistochemistry; human; 1:20
In order to evaluate the presence of cancer stem cells and EMT markers as prognostic markers for breast metaplastic carcinoma, Leica Biosystems cytokeratin 14 antibody (Novocastra, NCL-L-LL002) was used in immunohistochemistry on human samples at 1:20. Breast Cancer Res Treat (2015) ncbi
mouse monoclonal
  • immunohistochemistry - paraffin section; human; 1:100
In order to analyze the significance biologically and clinically of PARP1 protein expression in breast cancer, Leica Biosystems cytokeratin 14 antibody (Novocastra, LL002) was used in immunohistochemistry - paraffin section on human samples at 1:100. Breast Cancer Res Treat (2015) ncbi
mouse monoclonal
  • immunohistochemistry - paraffin section; human; 1:20
Leica Biosystems cytokeratin 14 antibody (Novocastra Laboratories, LL002) was used in immunohistochemistry - paraffin section on human samples at 1:20. Malays J Pathol (2014) ncbi
BD Biosciences
  • flow cytometry; human; fig 1b
In order to evaluate the myogenic potential and proliferative capacity of human alveolar mucosa cells, BD Biosciences cytokeratin 14 antibody (BD Pharmingen, 550953) was used in flow cytometry on human samples (fig 1b). Cell Cycle (2017) ncbi
mouse monoclonal (KA4)
  • immunohistochemistry; mouse; fig 6
BD Biosciences cytokeratin 14 antibody (BD pharmingen, 550951) was used in immunohistochemistry on mouse samples (fig 6). Sci Rep (2015) ncbi
Articles Reviewed
  1. Laly A, Sliogeryte K, Pundel O, Ross R, Keeling M, Avisetti D, et al. The keratin network of intermediate filaments regulates keratinocyte rigidity sensing and nuclear mechanotransduction. Sci Adv. 2021;7: pubmed publisher
  2. Biasci D, Smoragiewicz M, Connell C, Wang Z, Gao Y, Thaventhiran J, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc Natl Acad Sci U S A. 2020;117:28960-28970 pubmed publisher
  3. Yao C, Haensel D, Gaddam S, Patel T, Atwood S, Sarin K, et al. AP-1 and TGFß cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma. Nat Commun. 2020;11:5079 pubmed publisher
  4. Shin S, Itson Zoske B, Cai Y, Qiu C, Pan B, Stucky C, et al. Satellite glial cells in sensory ganglia express functional transient receptor potential ankyrin 1 that is sensitized in neuropathic and inflammatory pain. Mol Pain. 2020;16:1744806920925425 pubmed publisher
  5. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed publisher
  6. Gaglia G, Rashid R, Yapp C, Joshi G, Li C, Lindquist S, et al. HSF1 phase transition mediates stress adaptation and cell fate decisions. Nat Cell Biol. 2020;22:151-158 pubmed publisher
  7. Zhao L, Ke H, Xu H, Wang G, Zhang H, Zou L, et al. TDP-43 facilitates milk lipid secretion by post-transcriptional regulation of Btn1a1 and Xdh. Nat Commun. 2020;11:341 pubmed publisher
  8. Benhadou F, Glitzner E, Brisebarre A, Swedlund B, Song Y, Dubois C, et al. Epidermal autonomous VEGFA/Flt1/Nrp1 functions mediate psoriasis-like disease. Sci Adv. 2020;6:eaax5849 pubmed publisher
  9. Dagher E, Royer V, Buchet P, Abadie J, Loussouarn D, Campone M, et al. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer. BMC Cancer. 2019;19:1267 pubmed publisher
  10. Vaidyanathan S, Salahudeen A, Sellers Z, Bravo D, Choi S, Batish A, et al. High-Efficiency, Selection-free Gene Repair in Airway Stem Cells from Cystic Fibrosis Patients Rescues CFTR Function in Differentiated Epithelia. Cell Stem Cell. 2020;26:161-171.e4 pubmed publisher
  11. Jeong H, Lim K, Goldenring J, Nam K. Rab25 Deficiency Perturbs Epidermal Differentiation and Skin Barrier Function in Mice. Biomol Ther (Seoul). 2019;27:553-561 pubmed publisher
  12. Chen M, Reed R, Lane A. Chronic Inflammation Directs an Olfactory Stem Cell Functional Switch from Neuroregeneration to Immune Defense. Cell Stem Cell. 2019;25:501-513.e5 pubmed publisher
  13. Padmanaban V, Krol I, Suhail Y, Szczerba B, Aceto N, Bader J, et al. E-cadherin is required for metastasis in multiple models of breast cancer. Nature. 2019;573:439-444 pubmed publisher
  14. Ramani V, Lemaire C, Triboulet M, Casey K, Heirich K, Renier C, et al. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Breast Cancer Res. 2019;21:98 pubmed publisher
  15. Wang H, Xiang D, Liu B, He A, Randle H, Zhang K, et al. Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer. Cell. 2019;178:135-151.e19 pubmed publisher
  16. Welz P, Zinna V, Symeonidi A, Koronowski K, Kinouchi K, Smith J, et al. BMAL1-Driven Tissue Clocks Respond Independently to Light to Maintain Homeostasis. Cell. 2019;177:1436-1447.e12 pubmed publisher
  17. Bayer S, Grither W, Brenot A, Hwang P, Barcus C, Ernst M, et al. DDR2 controls breast tumor stiffness and metastasis by regulating integrin mediated mechanotransduction in CAFs. elife. 2019;8: pubmed publisher
  18. Yin M, Zhou H, Lin C, Long L, Yang X, Zhang H, et al. CD34+KLF4+ Stromal Stem Cells Contribute to Endometrial Regeneration and Repair. Cell Rep. 2019;27:2709-2724.e3 pubmed publisher
  19. Adams C, Htwe H, Marsh T, Wang A, Montoya M, Subbaraj L, et al. Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer. elife. 2019;8: pubmed publisher
  20. Miao Y, Yang H, Levorse J, Yuan S, Polak L, Sribour M, et al. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells. Cell. 2019;177:1172-1186.e14 pubmed publisher
  21. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  22. Krimpenfort P, Snoek M, Lambooij J, Song J, van der Weide R, Bhaskaran R, et al. A natural WNT signaling variant potently synergizes with Cdkn2ab loss in skin carcinogenesis. Nat Commun. 2019;10:1425 pubmed publisher
  23. Domenici G, Aurrekoetxea Rodríguez I, Simões B, Rábano M, Lee S, Millán J, et al. A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells. Oncogene. 2019;38:3151-3169 pubmed publisher
  24. Lee S, Ji H, Baek S, Lee A, Kim M, Park S, et al. Feline-type cystic basal cell tumor filled with abundant melanin pigment-rich fluid in a dog. J Vet Med Sci. 2019;81:269-273 pubmed publisher
  25. Mao S, Park M, Cabrera R, Christin J, Karagiannis G, Oktay M, et al. Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth. Breast Cancer Res. 2018;20:131 pubmed publisher
  26. Goldie S, Cottle D, Tan F, Roslan S, Srivastava S, Brady R, et al. Loss of GRHL3 leads to TARC/CCL17-mediated keratinocyte proliferation in the epidermis. Cell Death Dis. 2018;9:1072 pubmed publisher
  27. Li L, Guturi K, Gautreau B, Patel P, Saad A, Morii M, et al. Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis. J Clin Invest. 2018;128:4525-4542 pubmed publisher
  28. Pin D, Pendaries V, Keita Alassane S, Froment C, Amalric N, Cadiergues M, et al. Refined Immunochemical Characterization in Healthy Dog Skin of the Epidermal Cornification Proteins, Filaggrin, and Corneodesmosin. J Histochem Cytochem. 2019;67:85-97 pubmed publisher
  29. Sarkar M, Hile G, Tsoi L, Xing X, Liu J, Liang Y, et al. Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa. Ann Rheum Dis. 2018;77:1653-1664 pubmed publisher
  30. Schlögl E, Radeva M, Vielmuth F, Schinner C, Waschke J, Spindler V. Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris. Front Immunol. 2018;9:858 pubmed publisher
  31. Casey A, Sinha A, Singhania R, Livingstone J, Waterhouse P, Tharmapalan P, et al. Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilities. J Cell Biol. 2018;217:2951-2974 pubmed publisher
  32. Zhang Z, Zi Z, Lee E, Zhao J, Contreras D, South A, et al. Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis. Nat Med. 2018;24:617-627 pubmed publisher
  33. Komori T, Ono M, Hara E, Ueda J, Nguyen H, Nguyen H, et al. Type IV collagen α6 chain is a regulator of keratin 10 in keratinization of oral mucosal epithelium. Sci Rep. 2018;8:2612 pubmed publisher
  34. Rogerson C, Gissen P. VPS33B and VIPAR are essential for epidermal lamellar body biogenesis and function. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1609-1621 pubmed publisher
  35. Gesteira T, Sun M, Coulson Thomas Y, Yamaguchi Y, Yeh L, Hascall V, et al. Hyaluronan Rich Microenvironment in the Limbal Stem Cell Niche Regulates Limbal Stem Cell Differentiation. Invest Ophthalmol Vis Sci. 2017;58:4407-4421 pubmed publisher
  36. Aprile F, Källstig E, Limorenko G, Vendruscolo M, Ron D, Hansen C. The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation. Sci Rep. 2017;7:9039 pubmed publisher
  37. Kousa Y, Roushangar R, Patel N, Walter A, Marangoni P, Krumlauf R, et al. IRF6 and SPRY4 Signaling Interact in Periderm Development. J Dent Res. 2017;96:1306-1313 pubmed publisher
  38. Young C, Eckert R, Adhikary G, Crumrine D, Elias P, Blumenberg M, et al. Embryonic AP1 Transcription Factor Deficiency Causes a Collodion Baby-Like Phenotype. J Invest Dermatol. 2017;137:1868-1877 pubmed publisher
  39. Liao C, Booker R, Morrison S, Le L. Identification of hair shaft progenitors that create a niche for hair pigmentation. Genes Dev. 2017;31:744-756 pubmed publisher
  40. Shin J, Choi D, Sohn K, Kim J, Im M, Lee Y, et al. Targeted deletion of Crif1 in mouse epidermis impairs skin homeostasis and hair morphogenesis. Sci Rep. 2017;7:44828 pubmed publisher
  41. Wang X, Xia Q, Ni H, Ye S, Li R, Wang X, et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Hum Pathol. 2017;63:190-200 pubmed publisher
  42. Liu J, Hu F, Tang J, Tang S, Xia K, Wu S, et al. Homemade-device-induced negative pressure promotes wound healing more efficiently than VSD-induced positive pressure by regulating inflammation, proliferation and remodeling. Int J Mol Med. 2017;39:879-888 pubmed publisher
  43. Tao L, Xiang D, Xie Y, Bronson R, Li Z. Induced p53 loss in mouse luminal cells causes clonal expansion and development of mammary tumours. Nat Commun. 2017;8:14431 pubmed publisher
  44. Scheele C, Hannezo E, Muraro M, Zomer A, Langedijk N, van Oudenaarden A, et al. Identity and dynamics of mammary stem cells during branching morphogenesis. Nature. 2017;542:313-317 pubmed publisher
  45. Anderson P, Lynch T, Engelhardt J. Multipotent Myoepithelial Progenitor Cells Are Born Early during Airway Submucosal Gland Development. Am J Respir Cell Mol Biol. 2017;56:716-726 pubmed publisher
  46. Zorin V, Pulin A, Eremin I, Korsakov I, Zorina A, Khromova N, et al. Myogenic potential of human alveolar mucosa derived cells. Cell Cycle. 2017;16:545-555 pubmed publisher
  47. Hopkinson B, Klitgaard M, Petersen O, Villadsen R, Rønnov Jessen L, Kim J. Establishment of a normal-derived estrogen receptor-positive cell line comparable to the prevailing human breast cancer subtype. Oncotarget. 2017;8:10580-10593 pubmed publisher
  48. Britschgi A, Duss S, Kim S, Couto J, Brinkhaus H, Koren S, et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature. 2017;541:541-545 pubmed publisher
  49. Sørensen K, Meldgaard T, Melchjorsen C, Fridriksdottir A, Pedersen H, Petersen O, et al. Upregulation of Mrps18a in breast cancer identified by selecting phage antibody libraries on breast tissue sections. BMC Cancer. 2017;17:19 pubmed publisher
  50. Nguyen K, Lee E, Yue Y, Stork J, Pock L, North J, et al. Human polyomavirus 6 and 7 are associated with pruritic and dyskeratotic dermatoses. J Am Acad Dermatol. 2017;76:932-940.e3 pubmed publisher
  51. De Luca Johnson J, Zenali M. A Previously Undescribed Presentation of Mixed Adenoneuroendocrine Carcinoma. Case Rep Pathol. 2016;2016:9063634 pubmed
  52. Goreczny G, Ouderkirk Pecone J, Olson E, Krendel M, Turner C. Hic-5 remodeling of the stromal matrix promotes breast tumor progression. Oncogene. 2017;36:2693-2703 pubmed publisher
  53. Shatirishvili M, Burk A, Franz C, Pace G, Kastilan T, Breuhahn K, et al. Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress. Cell Death Dis. 2016;7:e2461 pubmed publisher
  54. Liu B, Tai Y, Achanta S, Kaelberer M, Caceres A, Shao X, et al. IL-33/ST2 signaling excites sensory neurons and mediates itch response in a mouse model of poison ivy contact allergy. Proc Natl Acad Sci U S A. 2016;113:E7572-E7579 pubmed
  55. Marichal T, Gaudenzio N, El Abbas S, Sibilano R, Zurek O, Starkl P, et al. Guanine nucleotide exchange factor RABGEF1 regulates keratinocyte-intrinsic signaling to maintain skin homeostasis. J Clin Invest. 2016;126:4497-4515 pubmed publisher
  56. Lin J, Kumari S, Kim C, Van T, Wachsmuth L, Polykratis A, et al. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation. Nature. 2016;540:124-128 pubmed publisher
  57. Pamarthy S, Mao L, Katara G, Fleetwood S, Kulshreshta A, Gilman Sachs A, et al. The V-ATPase a2 isoform controls mammary gland development through Notch and TGF-β signaling. Cell Death Dis. 2016;7:e2443 pubmed publisher
  58. Sheen M, Marotti J, Allegrezza M, Rutkowski M, Conejo Garcia J, Fiering S. Constitutively activated PI3K accelerates tumor initiation and modifies histopathology of breast cancer. Oncogenesis. 2016;5:e267 pubmed publisher
  59. Hsieh M, Wang H, Lee Y, Ko J, Chang Y. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation. Hum Pathol. 2017;61:9-18 pubmed publisher
  60. Zhang X, Hou W, Epperly M, Rigatti L, Wang H, Franicola D, et al. Evolution of malignant plasmacytoma cell lines from K14E7 Fancd2-/- mouse long-term bone marrow cultures. Oncotarget. 2016;7:68449-68472 pubmed publisher
  61. Altmeier S, Toska A, Sparber F, Teijeira A, Halin C, LeibundGut Landmann S. IL-1 Coordinates the Neutrophil Response to C. albicans in the Oral Mucosa. PLoS Pathog. 2016;12:e1005882 pubmed publisher
  62. Iacovides D, Rizki G, Lapathitis G, Strati K. Direct conversion of mouse embryonic fibroblasts into functional keratinocytes through transient expression of pluripotency-related genes. Stem Cell Res Ther. 2016;7:98 pubmed publisher
  63. Smirnova N, Schamberger A, Nayakanti S, Hatz R, Behr J, Eickelberg O. Detection and quantification of epithelial progenitor cell populations in human healthy and IPF lungs. Respir Res. 2016;17:83 pubmed publisher
  64. Berens E, Sharif G, Schmidt M, Yan G, Shuptrine C, Weiner L, et al. Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion. Oncogene. 2017;36:593-605 pubmed publisher
  65. Dai Y, Miao Y, Wu W, Li Y, D Errico F, Su W, et al. Ablation of Liver X receptors ? and ? leads to spontaneous peripheral squamous cell lung cancer in mice. Proc Natl Acad Sci U S A. 2016;113:7614-9 pubmed publisher
  66. Papafotiou G, Paraskevopoulou V, Vasilaki E, Kanaki Z, Paschalidis N, Klinakis A. KRT14 marks a subpopulation of bladder basal cells with pivotal role in regeneration and tumorigenesis. Nat Commun. 2016;7:11914 pubmed publisher
  67. Dianati E, Poiraud J, Weber Ouellette A, Plante I. Connexins, E-cadherin, Claudin-7 and ?-catenin transiently form junctional nexuses during the post-natal mammary gland development. Dev Biol. 2016;416:52-68 pubmed publisher
  68. Szalayova G, Ogrodnik A, Spencer B, Wade J, Bunn J, Ambaye A, et al. Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast Cancer Res Treat. 2016;157:461-74 pubmed publisher
  69. Kuga T, Sasaki M, Mikami T, Miake Y, Adachi J, Shimizu M, et al. FAM83H and casein kinase I regulate the organization of the keratin cytoskeleton and formation of desmosomes. Sci Rep. 2016;6:26557 pubmed publisher
  70. Ni T, Kuperwasser C. Premature polyadenylation of MAGI3 produces a dominantly-acting oncogene in human breast cancer. elife. 2016;5: pubmed publisher
  71. Fabbri R, Macciocca M, Vicenti R, Paradisi R, Klinger F, Pasquinelli G, et al. Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue. Future Oncol. 2016;12:1699-711 pubmed publisher
  72. Terakawa J, Rocchi A, Serna V, Bottinger E, Graff J, Kurita T. FGFR2IIIb-MAPK Activity Is Required for Epithelial Cell Fate Decision in the Lower Müllerian Duct. Mol Endocrinol. 2016;30:783-95 pubmed publisher
  73. Stewart M, Plante I, Penuela S, Laird D. Loss of Panx1 Impairs Mammary Gland Development at Lactation: Implications for Breast Tumorigenesis. PLoS ONE. 2016;11:e0154162 pubmed publisher
  74. Wierzbicka J, Zmijewski M, Antoniewicz J, Sobjanek M, Slominski A. Differentiation of Keratinocytes Modulates Skin HPA Analog. J Cell Physiol. 2017;232:154-66 pubmed publisher
  75. Yang S, Sun Y, Geng Z, Ma K, Sun X, Fu X. Abnormalities in the basement membrane structure promote basal keratinocytes in the epidermis of hypertrophic scars to adopt a proliferative phenotype. Int J Mol Med. 2016;37:1263-73 pubmed publisher
  76. Nair S, Zhang X, Chiang H, Jahid M, Wang Y, Garza P, et al. Genetic suppression reveals DNA repair-independent antagonism between BRCA1 and COBRA1 in mammary gland development. Nat Commun. 2016;7:10913 pubmed publisher
  77. Haikala H, Klefström J, Eilers M, Wiese K. MYC-induced apoptosis in mammary epithelial cells is associated with repression of lineage-specific gene signatures. Cell Cycle. 2016;15:316-23 pubmed publisher
  78. Crompton R, Williams H, Ansell D, Campbell L, Holden K, Cruickshank S, et al. Oestrogen promotes healing in a bacterial LPS model of delayed cutaneous wound repair. Lab Invest. 2016;96:439-49 pubmed publisher
  79. Mardaryev A, Liu B, Rapisarda V, Poterlowicz K, Malashchuk I, Rudolf J, et al. Cbx4 maintains the epithelial lineage identity and cell proliferation in the developing stratified epithelium. J Cell Biol. 2016;212:77-89 pubmed publisher
  80. Mandasari M, Sawangarun W, Katsube K, Kayamori K, Yamaguchi A, Sakamoto K. A facile one-step strategy for the generation of conditional knockout mice to explore the role of Notch1 in oroesophageal tumorigenesis. Biochem Biophys Res Commun. 2016;469:761-7 pubmed publisher
  81. Gopal K, Gowtham M, Sachin S, Ravishankar Ram M, Shankar E, Kamarul T. Attrition of Hepatic Damage Inflicted by Angiotensin II with α-Tocopherol and β-Carotene in Experimental Apolipoprotein E Knock-out Mice. Sci Rep. 2015;5:18300 pubmed publisher
  82. Schosserer M, Reynoso R, Wally V, Jug B, Kantner V, Weilner S, et al. Urine is a novel source of autologous mesenchymal stem cells for patients with epidermolysis bullosa. BMC Res Notes. 2015;8:767 pubmed publisher
  83. Ou L, Fang L, Tang H, Qiao H, Zhang X, Wang Z. Dickkopf Wnt signaling pathway inhibitor 1 regulates the differentiation of mouse embryonic stem cells in vitro and in vivo. Mol Med Rep. 2016;13:720-30 pubmed publisher
  84. Shin H, Pei Z, Martinez K, Rivera Viñas J, Méndez K, Cavallin H, et al. The first microbial environment of infants born by C-section: the operating room microbes. Microbiome. 2015;3:59 pubmed publisher
  85. Stempin S, Engel A, Winkler N, Buhrke T, Lampen A. Morphological and molecular characterization of the human breast epithelial cell line M13SV1 and its tumorigenic derivatives M13SV1-R2-2 and M13SV1-R2-N1. Cancer Cell Int. 2015;15:110 pubmed publisher
  86. van Jaarsveld M, van Kuijk P, Boersma A, Helleman J, Van Ijcken W, Mathijssen R, et al. miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway. Mol Cancer. 2015;14:196 pubmed publisher
  87. Gao L, Jiang Y, Mu L, Liu Y, Wang F, Wang P, et al. Efficient Generation of Mice with Consistent Transgene Expression by FEEST. Sci Rep. 2015;5:16284 pubmed publisher
  88. Fridriksdottir A, Kim J, Villadsen R, Klitgaard M, Hopkinson B, Petersen O, et al. Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture. Nat Commun. 2015;6:8786 pubmed publisher
  89. Jung M, Ryu Y, Kang G. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice. Pathol Res Pract. 2015;211:925-30 pubmed publisher
  90. Li Y, Adomat H, Guns E, Hojabrpour P, Duronio V, Curran T, et al. Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor. J Cell Physiol. 2016;231:1350-63 pubmed publisher
  91. Pajoohesh Ganji A, Pal Ghosh S, Tadvalkar G, Stepp M. K14 + compound niches are present on the mouse cornea early after birth and expand after debridement wounds. Dev Dyn. 2016;245:132-43 pubmed publisher
  92. Stewart M, Bechberger J, Welch I, Naus C, Laird D. Cx26 knockout predisposes the mammary gland to primary mammary tumors in a DMBA-induced mouse model of breast cancer. Oncotarget. 2015;6:37185-99 pubmed publisher
  93. Abou Kheir W, Eid A, El Merahbi R, Assaf R, Daoud G. A Unique Expression of Keratin 14 in a Subset of Trophoblast Cells. PLoS ONE. 2015;10:e0139939 pubmed publisher
  94. Kajimura J, Ito R, Manley N, Hale L. Optimization of Single- and Dual-Color Immunofluorescence Protocols for Formalin-Fixed, Paraffin-Embedded Archival Tissues. J Histochem Cytochem. 2016;64:112-24 pubmed publisher
  95. Todhunter M, Jee N, Hughes A, Coyle M, Cerchiari A, Farlow J, et al. Programmed synthesis of three-dimensional tissues. Nat Methods. 2015;12:975-81 pubmed publisher
  96. Koren S, Reavie L, Couto J, De Silva D, Stadler M, Roloff T, et al. PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours. Nature. 2015;525:114-8 pubmed publisher
  97. Wu Y, Feng G, Song J, Zhang Y, Yu Y, Huang L, et al. TrAmplification of Human Dental Follicle Cells by piggyBac Transposon - Mediated Reversible Immortalization System. PLoS ONE. 2015;10:e0130937 pubmed publisher
  98. Sauter J, Ambaye A, Mount S. Increased utilization, verification, and clinical implications of immunocytochemistry: Experience in a northern New England hospital. Diagn Cytopathol. 2015;43:688-95 pubmed publisher
  99. Cheung S, Boey Y, Koh V, Thike A, Lim J, Iqbal J, et al. Role of epithelial-mesenchymal transition markers in triple-negative breast cancer. Breast Cancer Res Treat. 2015;152:489-98 pubmed publisher
  100. Joshi P, Waterhouse P, Kannan N, Narala S, Fang H, Di Grappa M, et al. RANK Signaling Amplifies WNT-Responsive Mammary Progenitors through R-SPONDIN1. Stem Cell Reports. 2015;5:31-44 pubmed publisher
  101. Koh V, Lim J, Thike A, Cheok P, Thu M, Tan V, et al. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients. Breast Cancer Res Treat. 2015;152:293-304 pubmed publisher
  102. Gromova I, Gromov P, Honma N, Kumar S, Rimm D, Talman M, et al. High level PHGDH expression in breast is predominantly associated with keratin 5-positive cell lineage independently of malignancy. Mol Oncol. 2015;9:1636-54 pubmed publisher
  103. Swaminathan T, Basheer V, Kumar R, Kathirvelpandian A, Sood N, Jena J. Establishment and characterization of fin-derived cell line from ornamental carp, Cyprinus carpio koi, for virus isolation in India. In Vitro Cell Dev Biol Anim. 2015;51:705-13 pubmed publisher
  104. Muhanna N, Mepham A, Mohamadi R, Chan H, Khan T, Akens M, et al. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model. Nanomedicine. 2015;11:1613-20 pubmed publisher
  105. Kershaw S, Cummings J, Morris K, Tugwood J, Dive C. Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells. BMC Cancer. 2015;15:387 pubmed publisher
  106. Katanov C, Lerrer S, Liubomirski Y, Leider Trejo L, Meshel T, Bar J, et al. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-? and the NF-?B pathway. Stem Cell Res Ther. 2015;6:87 pubmed publisher
  107. Hines W, Yaswen P, Bissell M. Modelling breast cancer requires identification and correction of a critical cell lineage-dependent transduction bias. Nat Commun. 2015;6:6927 pubmed publisher
  108. Maeda M, Kanai N, Kobayashi S, Hosoi T, Takagi R, Ohki T, et al. Endoscopic cell sheet transplantation device developed by using a 3-dimensional printer and its feasibility evaluation in a porcine model. Gastrointest Endosc. 2015;82:147-52 pubmed publisher
  109. Sood N, Chaudhary D, Pradhan P, Verma D, Raja Swaminathan T, Kushwaha B, et al. Establishment and characterization of a continuous cell line from thymus of striped snakehead, Channa striatus (Bloch 1793). In Vitro Cell Dev Biol Anim. 2015;51:787-96 pubmed publisher
  110. Maity G, De A, Das A, Banerjee S, Sarkar S, Banerjee S. Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition. Lab Invest. 2015;95:702-17 pubmed publisher
  111. Matsusaki M, Fujimoto K, Shirakata Y, Hirakawa S, Hashimoto K, Akashi M. Development of full-thickness human skin equivalents with blood and lymph-like capillary networks by cell coating technology. J Biomed Mater Res A. 2015;103:3386-96 pubmed publisher
  112. Savci Heijink C, Halfwerk H, Hooijer G, Horlings H, Wesseling J, van de Vijver M. Retrospective analysis of metastatic behaviour of breast cancer subtypes. Breast Cancer Res Treat. 2015;150:547-57 pubmed publisher
  113. Aguiar C, Therrien J, Lemire P, Segura M, Smith L, Theoret C. Differentiation of equine induced pluripotent stem cells into a keratinocyte lineage. Equine Vet J. 2016;48:338-45 pubmed publisher
  114. Islam S, Mokhtari R, Noman A, Uddin M, Rahman M, Azadi M, et al. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer. Mol Carcinog. 2016;55:537-51 pubmed publisher
  115. Ahmed H, Abdul Gader Suliman R, Abd El Aziz M, Alshammari F. Immunohistochemical expression of cytokeratins and epithelial membrane protein 2 in nasopharyngeal carcinoma and its potential implications. Asian Pac J Cancer Prev. 2015;16:653-6 pubmed
  116. Oon M, Thike A, Tan S, Tan P. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast. Breast Cancer Res Treat. 2015;150:31-41 pubmed publisher
  117. Muscatello L, Sarli G, Beha G, Asproni P, Millanta F, Poli A, et al. Validation of tissue microarray for molecular profiling of canine and feline mammary tumours. J Comp Pathol. 2015;152:153-60 pubmed publisher
  118. Zheng L, Cardaci S, Jerby L, MacKenzie E, Sciacovelli M, Johnson T, et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat Commun. 2015;6:6001 pubmed publisher
  119. Progatzky F, Sangha N, Yoshida N, McBrien M, Cheung J, Shia A, et al. Dietary cholesterol directly induces acute inflammasome-dependent intestinal inflammation. Nat Commun. 2014;5:5864 pubmed publisher
  120. Green A, Caracappa D, Benhasouna A, Alshareeda A, Nolan C, Macmillan R, et al. Biological and clinical significance of PARP1 protein expression in breast cancer. Breast Cancer Res Treat. 2015;149:353-62 pubmed publisher
  121. Tozbikian G, Brogi E, Kadota K, Catalano J, Akram M, Patil S, et al. Mesothelin expression in triple negative breast carcinomas correlates significantly with basal-like phenotype, distant metastases and decreased survival. PLoS ONE. 2014;9:e114900 pubmed publisher
  122. Suzuki D, Sahu R, Leu N, Senoo M. The carboxy-terminus of p63 links cell cycle control and the proliferative potential of epidermal progenitor cells. Development. 2015;142:282-90 pubmed publisher
  123. BaÅŸak K, KiroÄŸlu K. Multiple oncocytic cystadenoma with intraluminal crystalloids in parotid gland: case report. Medicine (Baltimore). 2014;93:e246 pubmed publisher
  124. DiTommaso T, Cottle D, Pearson H, Schlüter H, Kaur P, Humbert P, et al. Keratin 76 is required for tight junction function and maintenance of the skin barrier. PLoS Genet. 2014;10:e1004706 pubmed publisher
  125. Beck A, Brooks A, Zeiss C. Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta). Comp Med. 2014;64:314-22 pubmed
  126. Pattabiraman C, Hong S, Gunasekharan V, Pranatharthi A, Bajaj J, Srivastava S, et al. CD66+ cells in cervical precancers are partially differentiated progenitors with neoplastic traits. Cancer Res. 2014;74:6682-92 pubmed publisher
  127. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  128. Contreras Jurado C, García Serrano L, Martínez Fernández M, Ruiz Llorente L, Paramio J, Aranda A. Impaired hair growth and wound healing in mice lacking thyroid hormone receptors. PLoS ONE. 2014;9:e108137 pubmed publisher
  129. Cottle D, Ursino G, Ip S, Jones L, DiTommaso T, Hacking D, et al. Fetal inhibition of inflammation improves disease phenotypes in harlequin ichthyosis. Hum Mol Genet. 2015;24:436-49 pubmed publisher
  130. Li L, Fan X, Xia Q, Rao Q, Liu B, Yu B, et al. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis. Hum Pathol. 2014;45:2247-54 pubmed publisher
  131. Kuroda N, Fujishima N, Hayes M, Moritani S, Ichihara S. Encapsulated papillary carcinoma, apocrine type, of the breast. Malays J Pathol. 2014;36:139-43 pubmed
  132. Sajin M, Luchian M, Hodorogea Prisăcaru A, Dumitru A, Pătraşcu O, Costache D, et al. Trichilemmal carcinoma - a rare cutaneous malignancy: report of two cases. Rom J Morphol Embryol. 2014;55:687-91 pubmed
  133. Costache M, Pătraşcu O, Dumitru A, Costache D, Voinea L, Simionescu O, et al. Histopathological findings concerning ocular melanomas. Rom J Morphol Embryol. 2014;55:649-53 pubmed
  134. Guan H, Tan J, Zhang F, Gao L, Bai L, Qi D, et al. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12. Histopathology. 2015;66:781-90 pubmed publisher
  135. Ouyang H, Xue Y, Lin Y, Zhang X, Xi L, Patel S, et al. WNT7A and PAX6 define corneal epithelium homeostasis and pathogenesis. Nature. 2014;511:358-61 pubmed publisher
  136. Kutten J, McGovern D, Hobson C, Luffy S, Nieponice A, Tobita K, et al. Decellularized tracheal extracellular matrix supports epithelial migration, differentiation, and function. Tissue Eng Part A. 2015;21:75-84 pubmed publisher
  137. Kim C, Pasparakis M. Epidermal p65/NF-?B signalling is essential for skin carcinogenesis. EMBO Mol Med. 2014;6:970-83 pubmed publisher
  138. Kaisani A, Delgado O, Fasciani G, Kim S, Wright W, Minna J, et al. Branching morphogenesis of immortalized human bronchial epithelial cells in three-dimensional culture. Differentiation. 2014;87:119-26 pubmed publisher
  139. Balk Møller E, Kim J, Hopkinson B, Timmermans Wielenga V, Petersen O, Villadsen R. A marker of endocrine receptor-positive cells, CEACAM6, is shared by two major classes of breast cancer: luminal and HER2-enriched. Am J Pathol. 2014;184:1198-208 pubmed publisher
  140. Motomura K, Sumino H, Noguchi A, Horinouchi T, Nakanishi K. Sentinel nodes identified by computed tomography-lymphography accurately stage the axilla in patients with breast cancer. BMC Med Imaging. 2013;13:42 pubmed publisher
  141. Kidwai F, Cao T, Lu K. Differentiation of epidermal keratinocytes from human embryonic stem cells. Methods Mol Biol. 2014;1195:13-22 pubmed publisher
  142. Yasuno K, Nishiyama S, Kobayashi R, Yoshimura H, Takahashi K, Omachi T, et al. Proliferative lesions of intra-epidermal cytokeratin CAM5.2-positive cells in canine nipples. J Comp Pathol. 2014;150:18-26 pubmed publisher
  143. Bulysheva A, Bowlin G, Petrova S, Yeudall W. Enhanced chemoresistance of squamous carcinoma cells grown in 3D cryogenic electrospun scaffolds. Biomed Mater. 2013;8:055009 pubmed publisher
  144. Motomura K, Izumi T, Tateishi S, Sumino H, Noguchi A, Horinouchi T, et al. Correlation between the area of high-signal intensity on SPIO-enhanced MR imaging and the pathologic size of sentinel node metastases in breast cancer patients with positive sentinel nodes. BMC Med Imaging. 2013;13:32 pubmed publisher
  145. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed publisher
  146. Vlug E, van de Ven R, Vermeulen J, Bult P, van Diest P, Derksen P. Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer. Cell Oncol (Dordr). 2013;36:375-84 pubmed publisher
  147. Dai J, Brooks Y, Lefort K, Getsios S, Dotto G. The retinoid-related orphan receptor ROR? promotes keratinocyte differentiation via FOXN1. PLoS ONE. 2013;8:e70392 pubmed publisher
  148. Hosokawa M, Kenmotsu H, Koh Y, Yoshino T, Yoshikawa T, Naito T, et al. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. PLoS ONE. 2013;8:e67466 pubmed publisher
  149. Sjödahl G, Lövgren K, Lauss M, Patschan O, Gudjonsson S, Chebil G, et al. Toward a molecular pathologic classification of urothelial carcinoma. Am J Pathol. 2013;183:681-91 pubmed publisher
  150. Ohta K, Taki M, Ogawa I, Ono S, Mizuta K, Fujimoto S, et al. Malignant ossifying fibromyxoid tumor of the tongue: case report and review of the literature. Head Face Med. 2013;9:16 pubmed publisher
  151. Hughes M, Jiang T, Lin S, Leung Y, Kobielak K, Widelitz R, et al. Disrupted ectodermal organ morphogenesis in mice with a conditional histone deacetylase 1, 2 deletion in the epidermis. J Invest Dermatol. 2014;134:24-32 pubmed publisher
  152. Nassiri F, Scheithauer B, Corwin D, Kaplan H, Mayberg M, Cusimano M, et al. Invasive thymoma metastatic to the cavernous sinus. Surg Neurol Int. 2013;4:74 pubmed publisher
  153. Xing C, Fu X, Sun X, Guo P, Li M, Dong J. Different expression patterns and functions of acetylated and unacetylated Klf5 in the proliferation and differentiation of prostatic epithelial cells. PLoS ONE. 2013;8:e65538 pubmed publisher
  154. Yockey L, Demehri S, Turkoz M, Turkoz A, Ahern P, Jassim O, et al. The absence of a microbiota enhances TSLP expression in mice with defective skin barrier but does not affect the severity of their allergic inflammation. J Invest Dermatol. 2013;133:2714-2721 pubmed publisher
  155. Mao X, Li H, Sano Y, Gaestel M, Mo Park J, Payne A. MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris. J Invest Dermatol. 2014;134:68-76 pubmed publisher
  156. Yang G, Li J, Jin H, Ding H. Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study. Diagn Pathol. 2013;8:14 pubmed publisher
  157. Weli S, Aamelfot M, Dale O, Koppang E, Falk K. Infectious salmon anaemia virus infection of Atlantic salmon gill epithelial cells. Virol J. 2013;10:5 pubmed publisher
  158. Beha G, Brunetti B, Asproni P, Muscatello L, Millanta F, Poli A, et al. Molecular portrait-based correlation between primary canine mammary tumor and its lymph node metastasis: possible prognostic-predictive models and/or stronghold for specific treatments?. BMC Vet Res. 2012;8:219 pubmed publisher
  159. Beha G, Sarli G, Brunetti B, Sassi F, Ferrara D, Benazzi C. Morphology of the myoepithelial cell: immunohistochemical characterization from resting to motile phase. ScientificWorldJournal. 2012;2012:252034 pubmed publisher
  160. Krolewski R, Packard A, Schwob J. Global expression profiling of globose basal cells and neurogenic progression within the olfactory epithelium. J Comp Neurol. 2013;521:833-59 pubmed publisher
  161. Lv S, Song Y, Xu J, Shu H, Zhou Z, An N, et al. A novel TP53 somatic mutation involved in the pathogenesis of pediatric choroid plexus carcinoma. Med Sci Monit. 2012;18:CS37-41 pubmed
  162. Sohn W, Gwon G, An C, Moon C, Bae Y, Yamamoto H, et al. Morphological evidences in circumvallate papilla and von Ebners' gland development in mice. Anat Cell Biol. 2011;44:274-83 pubmed publisher
  163. Khoja L, Backen A, Sloane R, Menasce L, Ryder D, Krebs M, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106:508-16 pubmed publisher
  164. Kap M, Smedts F, Oosterhuis W, Winther R, Christensen N, Reischauer B, et al. Histological assessment of PAXgene tissue fixation and stabilization reagents. PLoS ONE. 2011;6:e27704 pubmed publisher
  165. Brusevold I, Husvik C, Schreurs O, Schenck K, Bryne M, Søland T. Induction of invasion in an organotypic oral cancer model by CoCl2, a hypoxia mimetic. Eur J Oral Sci. 2010;118:168-76 pubmed publisher
  166. Tompkins D, Besnard V, Lange A, Wert S, Keiser A, Smith A, et al. Sox2 is required for maintenance and differentiation of bronchiolar Clara, ciliated, and goblet cells. PLoS ONE. 2009;4:e8248 pubmed publisher
  167. Gil da Costa R, Santos M, Amorim I, Lopes C, Pereira P, Faustino A. An immunohistochemical study of feline endometrial adenocarcinoma. J Comp Pathol. 2009;140:254-9 pubmed publisher
  168. Rhee K, Wu S, Wu X, Huso D, Karim B, Franco A, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun. 2009;77:1708-18 pubmed publisher
  169. Rodriguez F, Scheithauer B, Giannini C, Bryant S, Jenkins R. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer. 2008;113:2779-89 pubmed publisher
  170. Boone J, van Hillegersberg R, van Diest P, Offerhaus G, Rinkes I, Kate F. Validation of tissue microarray technology in squamous cell carcinoma of the esophagus. Virchows Arch. 2008;452:507-14 pubmed publisher
  171. Goldstein N, Decker D, Severson D, Schell S, Vicini F, Margolis J, et al. Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer. 2007;110:1687-96 pubmed
  172. Lu S, Yu G, Zhu Y, Archer M. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer. 2005;116:847-52 pubmed
  173. Gilbert S, Loranger A, Marceau N. Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells. Mol Cell Biol. 2004;24:7072-81 pubmed
  174. Song S, Park S, Kim S, Suh Y. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas. Pathol Int. 2004;54:603-10 pubmed
  175. Chung C, Parker J, Karaca G, Wu J, Funkhouser W, Moore D, et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell. 2004;5:489-500 pubmed
  176. Kokenyesi R, Murray K, Benshushan A, Huntley E, Kao M. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression. Gynecol Oncol. 2003;89:60-72 pubmed